Introduction

For pharmaceutical, biotech, and medical device companies, medical congresses are pivotal opportunities for scientific exchange, professional education, and brand visibility. However, these events operate within a highly regulated U.S. environment governed by a web of federal laws, state regulations, and industry codes. A single mistake can lead to severe financial penalties, government investigations, and irreparable reputational damage. This reality makes a robustU.S. medical congress compliance checklistnot just a best practice, but an essential tool for risk management. This guide provides a detailed, end-to-end framework for ensuring every aspect of congress participation—from booth design and HCP interactions to data reporting—is meticulously planned and executed in full compliance with all applicable standards, including the Physician Payments Sunshine Act and the PhRMA Code on Interactions with Healthcare Professionals.

Our methodology is built on a proactive, multi-stage approach. We will dissect the congress lifecycle into four key phases: Pre-Congress Planning (6-12 months out), Final Preparation (1-3 months out), On-Site Execution (event duration), and Post-Congress Reconciliation (up to 3 months after). For each phase, we will define critical tasks, assign roles, and establish key performance indicators (KPIs). Success will be measured by metrics such as a 0% rate of compliance-related incidents, 100% accuracy in Transfer of Value (ToV) reporting, adherence to budget within a <3% variance, and positive feedback from both internal teams and engaged HCPs. This structured approach transforms compliance from a reactive necessity into a strategic advantage, fostering trust and enabling meaningful scientific dialogue.

Vision, values ​​and proposal

Focus on results and measurement

Our vision is to position compliance as an enabler of ethical innovation and trusted partnerships, not a barrier to engagement. We operate on the core values ​​of transparency, integrity, and patient-centricity. Every interaction and material sponsored at a medical congress must ultimately serve the interests of patient care through legitimate scientific exchange and education. We apply the 80/20 principle by focusing compliance resources on high-risk areas: direct HCP interactions, promotional materials, and Transfers of Value (ToV). Our standards are benchmarked against the Office of Inspector General (OIG) Compliance Program Guidance, FDA regulations on advertising and promotion, and the AdvaMed and PhRMA codes, ensuring our framework is both comprehensive and practical.

• Principle of Transparency: All interactions and transfers of value are documented meticulously for accurate Sunshine Act reporting.
• Legitimate Need Criterion: All sponsored activities, including meals and educational items, must be modest and directly related to a legitimate educational or business purpose.
• Separation of Functions: Clear firewalls are maintained between commercial (sales/marketing) and non-commercial (medical affairs/R&D) functions to prevent any perception of improper influence.
• Risk Decision Matrix: Activities are categorized as low, medium, or high risk. A high-risk activity, such as a product theater presentation, requires multiple levels of legal and compliance review, whereas a low-risk activity, like distributing a pre-approved scientific reprint, has an expedited approval process.

Services, profiles and performance

Portfolio and professional profiles

A dedicated compliance function, whether internal or outsourced, provides a suite of services crucial for navigating medical congresses. These are typically managed by a team including a Chief Compliance Officer, Congress Compliance Leads, and Reporting Analysts. The core service is the operationalization of theU.S. medical congress compliance checklist, ensuring it is integrated into every department’s workflow. Services include pre-clearance of all promotional and educational materials, training for all attending staff, on-site monitoring and real-time consultation, and post-event auditing and aggregate spend reporting.

Operational process

1. Diagnosis Phase (6 months before): Review the overall congress strategy, identify all planned HCP interactions (advisory boards, speaker programs, booth engagements), and conduct a preliminary risk assessment. KPI: 100% of planned activities identified and risk-scored.
2. Planning Phase (3-5 months before): Develop a specific compliance plan for the event, including budget allocation for compliance activities (e.g., data capture technology), training schedules, and material review deadlines. KPI: Compliance plan approved and distributed 90 days prior to the event.
3. Implementation Phase (1-2 months before): Execute staff training, complete review of all materials, and finalize logistical arrangements for on-site monitoring. KPI: 100% of attending staff complete mandatory compliance training with a >90% assessment score.
4. Execution Phase (During the congress): Conduct on-site monitoring, provide real-time guidance to staff, and manage the compliant capture of all ToV data. KPI: Zero on-site compliance violations reported; 100% of ToV captured within 24 hours.
5. Closing Phase (1-3 months later): Reconcile all captured data, conduct a post-mortem review, audit expense reports, and prepare and submit the final Sunshine Act report. KPI: Sunshine Act data submitted with 100% accuracy and before the deadline.

Tables and examples

Objective	Indicators	Actions	Expected result
Prevent off-label promotion	Number of off-label inquiries handled; Post-event staff survey on compliance confidence	Mandatory training on product label and appropriate response protocols; On-site Medical Affairs presence	0 confirmed instances of off-label promotion by company staff; 95% of inquiries correctly triaged to Medical Affairs Ensure accurate Sunshine Act reporting Percentage of error in captured Time of Vehicle (ToV) data; Time to data reconciliation Implement a credential scanning application for ToV capture; 100% audit of staff expense reports Data error rate <0.5%; Reconciliation completed within 30 days of the event Comply with the PhRMA Code for meals provided to Health Care Providers (HCPs) Average cost per meal per HCP; Documentation of the educational purpose of meals Establish pre-approved meal cost limits; Prohibit meals without a substantial educational presentation.	Average cost per meal remains below the internal threshold (e.g., $125); 100% of meals have a documented agenda and attendee list. … This includes reviewing booth designs to ensure they are not overly promotional and that claims are supported by data, verifying that all printed materials have received prior legal and regulatory approval (with job codes clearly visible), and ensuring any technology used for HCP engagement (e.g., interactive displays, data capture apps) is secure and privacy-compliant. A detailed project plan with clear deadlines for each deliverable is essential.Documentation Checklist: Are all speaker contracts on file? Do we have FDA approval (Form 2253) for all promotional materials? Are confidentiality agreements with vendors signed? Contingency Plan for Materials: What happens if the shipment of approved brochures is delayed? Have approved digital copies available for viewing on tablets. What happens if a booth graphic arrives damaged? Have a plan in place for replacing or eliminating the affected section. Supplier Coordination: Mandatory kickoff meeting with all suppliers to review company compliance guidelines. Compliance clauses included in all supplier contracts. Implementation Schedule: Deadlines for the first draft of the booth design (T-6 months), final submission of materials for review (T-3 months), completion of staff training (T-1 month), and pre-event booth audit (T-2 days).

Content and/or Media that Convert

Messages, formats and conversions

Compliant content is not just about avoiding violations; it’s about creating clear, fair-balanced, and valuable educational materials that resonate with HCPs. The “hook” for content at a medical congress should be scientific data, not a marketing slogan. Calls to Action (CTAs) must be carefully worded to avoid any implication of a quid pro quo. For example, instead of “Visit our booth to receive a gift card,” use “Visit our booth to discuss the latest clinical trial data with a medical expert.” We use A/B testing on digital content (e.g., pre-congress emails) to see which scientifically-focused subject lines generate higher open rates among registered HCPs. The ultimate conversion metric in a compliant context is not a sale, but a meaningful scientific exchange, measured by the number of in-depth conversations with Medical Science Liaisons (MSLs) or requests for scientific reprints. The development of a U.S. medical congress compliance checklist for content is a non-negotiable step in this process.

• Phase 1: Message Planning (T-6 months): The medical affairs and marketing teams align on the key scientific messages to be communicated, based on published data. Responsible: Marketing Director, Medical Director.
• Phase 2: Content Development (T-5 months): Initial drafts of all materials (booth panels, visual aids, brochures, digital content) are created by the creative agency. Responsible: Product Manager.
• Phase 3: Legal, Medical, and Regulatory Review (T-4 months): All materials are submitted through a formal promotional review system (such as Veeva Vault PromoMats). Reviewers verify the accuracy of claims, proper balance, consistency with the product label, and compliance with FDA guidelines. Responsible: Promotions Review Committee (PRC).Phase 4: Review and Production (2 months): The reviewed materials are finalized and sent to production. Each piece is assigned a unique job code for tracking. Responsible: Project Manager.

  Phase 5: Delivery and Final Audit (1 week): All physical materials arrive at the conference venue. The Compliance Lead conducts a final audit to ensure that only approved materials are present at the booth. Responsible: Compliance Leader.

Training and employability

Demand-driven catalog

Effective training is the most critical control to ensure on-site compliance.

All company representatives attending a congress—including sales, marketing, medical affairs, R&D, and senior executives—must complete mandatory, role-based compliance training. This is not a one-size-fits-all program. The training must be practical, using scenarios they will actually encounter.

Module 1: Conference Compliance Fundamentals (For All Personnel): Covers the PhRMA/AdvaMed Code, the Sunshine Act, and internal company policies regarding interactions with healthcare professionals. Includes an overview of the separation between commercial and medical functions.

• Module 2: Compatible Commercial Interactions (For Sales and Marketing): Focuses on in-etiquette promotion, how to respond to out-of-etiquette inquiries (referring to Medical Affairs), the rules for promotional items, and capturing ToV data.
• Module 3: Scientific Exchange and Question Response (For Medical Affairs/MSL): Delves into the nuances of discussing out-of-etiquette data in response to unsolicited requests, maintaining a non-promotional stance, and documenting interactions.
• Module 4: Rules of Engagement for Executives (For Senior Leadership): Specialized training for executives who may not be as familiar with the day-to-day rules, focusing on high-level interactions and public statements.
• Module 5: Scenario Simulation at the Booth: An interactive session where teams practice handling role-playing scenarios, such as an HCP requesting off-label information, a competitor trying to gather intelligence, or an HCP complaining about a product.Methodology

  Our training methodology blends e-learning modules with live, interactive sessions. Comprehension is assessed via a scored test at the end of each module, with a passing score of 90% required. The cornerstone is the scenario-based simulation, evaluated using a rubric that measures the employee’s ability to identify the compliance issue, articulate the correct policy, and execute the appropriate action (e.g., handing off to an MSL). Successful completion of all required training is a prerequisite for receiving a congress badge, linking employability and participation directly to compliance proficiency.

  Operational Processes and Quality Standards

  From Request to Execution

  A standardized operational process ensures consistency and accountability across all congress activities. This pipeline moves from initial strategy to final reporting, with clear gates and approval requirements at each step.

• Diagnosis (T-9 months): The marketing team presents a strategic proposal for the congress to the steering committee. Deliverable: Summary of the congress strategy. Acceptance Criteria: Budget approval and alignment with brand objectives.
• Compliance Proposal (T-8 months): The compliance department develops a support plan and resource budget based on the approved strategy. Deliverable: Congress Risk and Compliance Plan. Acceptance Criteria: Approval by the Compliance Director and the Head of the Business Unit.Pre-production (T-7 to T-2 months): Teams execute their plans (content development, logistics, vendor contracting) following the compliance plan. Deliverable: All materials approved in the PRC system, all staff enrolled in training. Acceptance Criteria: Compliance Lead’s readiness report confirming that all elements are ready.

  Execution (During the Congress): Implementation of the plan on-site, with real-time monitoring. Deliverable: Daily interaction logs, Time of View data capture. Acceptance Criteria: Absence of escalated compliance incidents.

• Closure and Reporting (T+1 to T+3 months): Reconciliation of all expenses and Time of Vehicle (ToV) data, lessons learned session, and preparation of regulatory reports. Deliverable: Final aggregate expense report, lessons learned report. Acceptance Criteria: Submission of Sunshine Act data before the deadline.

• Quality Control

  Quality control is embedded throughout the process through a system of checks and balances, defined roles, and clear escalation paths. Service Level Agreements (SLAs) are established for key processes, such as a 10-day turnaround for the initial review of promotional materials.

  • Roles: The Business Owner (Marketing) is responsible for the strategy. The Process Owner (Project Manager) is responsible for execution. The Quality Assurance Officer (Compliance/Legal) is responsible for oversight and approval.Escalation: Any dispute or compliance issue that cannot be resolved by the on-site Compliance Lead is immediately escalated to the Compliance Director and Legal Counsel.

    Acceptance Indicators: Material is not considered “approved” until all designated reviewers have electronically signed it. HCP expenses are non-reimbursable without a detailed receipt and documented business purpose.

    SLAs: Response time for on-site compliance inquiries must be less than 15 minutes. Credential scan data reconciliation must be completed within 48 hours of the congress’s end.

  On-SiteDaily ToV logs; Compliance query logAccuracy of real-time data capture; Number of compliance queries per dayRisk:

  Phase	Deliverables	Control Indicators	Risks and Mitigation
  Pre-Congress	Compliance Plan Approved; Materials 100% Reviewed; Staff 100% Trained	% Completion of Tasks in the Project Plan; Training Test Scores	Risk: Last-minute material approvals causing delays. Mitigation: Strict deadlines for submitting materials (T-3 months).

  Inappropriate staff conversations.Mitigation: Active monitoring at the booth by the Compliance Lead; Scenario-based training.

  Post-Conference

  Completed aggregate expense report; Lessons learned report

  % deviation between captured ToVs and expense reports; Audit Completion RateRisk: Incomplete or inaccurate Sunshine Act data. Mitigation: Three-way reconciliation process (scan data, expense reports, vendor records).

Application Cases and Scenarios

Case 1: Launching a Blockbuster Product at a Large-Scale Cardiology Congress

Scenario: A large pharmaceutical company is launching a new cardiovascular drug at the annual meeting of the American College of Cardiology (ACC). The budget is $5 million, with over 100 employees (sales, marketing, physicians, executives) in attendance. The goal is to maximize visibility and educational engagement surrounding the newly published Phase 3 trial data.

Compliance Challenges: High volume of interactions with HCP; risk of enthusiasm leading to off-the-cuff conversations; managing a large promotional booth alongside a separate scientific exchange booth; coordinating multiple ancillary events (symposia, investigator meetings); and accurately capturing thousands of value transfers.

Compliance Checklist Solution:

1. Governance Structure (T-9 months): A “Congress Compliance Steering Committee” is established with leaders from each function. Two on-site Compliance Leaders are appointed: one for the promotional booth and one for Medical Affairs events.
2. Booth Zoning (T-6 months): The booth design is divided into clear zones. A “Promotional Zone” staffed by marketing and sales personnel, featuring branded materials and strictly on-label content. A separate “Scientific Exchange Zone,” staffed exclusively by MSL/Physician personnel, featuring non-promotional content and the opportunity for in-depth scientific discussions.Advanced Training (T-2 months): In addition to standard training, intensive simulation sessions focused on the launch are conducted. Scenarios include how to handle questions comparing the new drug to off-label competitors and how to transition a conversation from the promotional booth to an MSL in the scientific zone.

   ToV Technology Solution (T-1 month): A ToV capture system based on a custom application is implemented. Each employee has the application on their phone, which is linked to credential scanning. The application automatically categorizes the ToV (e.g., “modest food,” “educational item”) and requires a business purpose to be entered for each scan. The cost per HCP is tracked in real time against preset limits.

3. On-Site Monitoring: Compliance Leaders conduct hourly sweeps of the booth, listening to conversations, ensuring the correct staff are in the correct areas, and verifying that only approved materials are on display. They hold a 15-minute briefing each morning with all staff to reinforce key compliance messages.

Results (KPIs): Zero compliance incidents reported. ToV data was reconciled with 99.8% accuracy within 15 days of the conference. A post-event survey showed that 95% of staff felt “very confident” in their ability to handle compliance interactions. The total cost of the conference remained within 2% of the budget. ROI was measured by the number of qualified MSL engagements, which exceeded the target by 30%.

Case 2: First Investigator Meeting of a Small Biotech Company

Scenario: A clinical-stage biotech company with limited resources is hosting its first investigator meeting at the American Society of Clinical Oncology (ASCO) conference. The goal is to educate principal investigators about the protocol for an upcoming Phase 2 trial. Thirty investigators and ten company employees are attending.

Compliance Challenges: Limited budget for dedicated compliance support; high risk of discussing preclinical data or future plans that could be perceived as promotional; ensuring that payments to investigators for their time are fair market value and properly documented; and avoid the appearance of an “entertainment” event.

Compliance Checklist Solution:

1. Cost-Effective Compliance Planning (T-4 months): The company hires an hourly compliance consultant instead of a full-time firm. The consultant helps develop a simplified checklist and SOP for the event.
2. Fair Market Value (FMV) Analysis (T-3 months): A formal FMV analysis is conducted to determine the hourly rate for the researcher’s consulting, based on their expertise and experience. Clear contracts detailing the scope of services and compensation are sent to each researcher.
3. Agenda Focus (T-2 months): The meeting agenda is designed to be content-intensive, with minimal downtime. Over 80% of the time is spent on scientific presentations and Q&A sessions about the protocol. Meals are modest and served on-site to maximize time. Spouses and guests are not sponsored.
4. Internal Team Training (T-1 month): The compliance consultant conducts a 2-hour training session for the 10 attending staff members, focusing on the specific rules for interactions at researcher meetings and the importance of adhering to the agenda.
5. Documentation and Reporting (Post-event): A single “Event Compliance Master File” is created containing the agenda, the signed attendee list, researcher contracts, receipts for all expenses, and a summary of the minutes. All payments (transfers of value) are recorded in a spreadsheet for aggregated expense reporting.Results (KPIs): The event was completed 10% under budget. 100% of transfers of value were documented and reported. Investigator feedback (NPS of +50) was overwhelmingly positive, highlighting the educational and professional nature of the event. No compliance issues arose.

   Case 3: Navigating a Hybrid Neurology Congress

   Scenario: A mid-sized medical device company participates in a hybrid congress, with both a physical and a virtual booth. El objetivo es interactuar tanto con los asistentes presenciales como con los virtuales para demostrar un nuevo dispositivo de neuroestimulación.

   Desafíos de Cumplimiento: Seguimiento de las interacciones virtuales con HCP para el reporte de la Sunshine Act; asegurar que el contenido digital en el stand virtual sea compatible y no se pueda descargar o compartir indebidamente; gestionar la privacidad de los datos de los HCP que se registran en la plataforma virtual; y formar al personal sobre cómo interactuar de manera compatible en un entorno de chat/video.

   Solución de la Lista de Verificación de Cumplimiento:

   1. Debida Diligencia de la Plataforma (T-5 meses): Antes de firmar el contrato, el equipo de cumplimiento revisa la plataforma virtual del congreso. Evalúan sus capacidades de seguimiento de datos (¿puede identificar de manera única a los HCP?), los controles de seguridad (¿está encriptado el chat?) y las características de control de contenido (¿se pueden bloquear las descargas de materiales no aprobados?).
   2. Estrategia de Contenido Digital (T-4 meses): Se decide que el stand virtual solo contendrá contenido que sea apropiado para una audiencia amplia y no solicitará información que pueda llevar a una discusión fuera de la etiqueta. Las discusiones detalladas se dirigen a chats de video 1 a 1 con MSLs, que se inician a través de un portal de solicitud. Todos los PDFs son “solo para visualización” y no se pueden descargar.
   3. Definición de “Transferencia de Valor” Virtual (T-3 meses): La empresa establece una política interna clara sobre lo que constituye un ToV en el entorno virtual. El acceso a contenido bajo demanda no se considera un ToV. Sin embargo, si un HCP asiste a una sesión de preguntas y respuestas en vivo con un experto remunerado, una parte del costo del experto se asigna a ese HCP y se reporta.
   4. Formación en Etiqueta Virtual (T-1 mes): El personal recibe formación sobre cómo interactuar en la plataforma. Las reglas incluyen: no usar un lenguaje informal o emojis en los chats con HCP; iniciar todas las conversaciones de video con un guion aprobado; y cómo documentar una solicitud no solicitada que llega a través del chat antes de transferirla a Asuntos Médicos.
   5. Proceso de Reconciliación de Datos (Post-evento): Se extraen los datos del stand físico (escaneos de credenciales) y del stand virtual (registros de chat, registros de visualización de videos, registros de asistencia a sesiones). Estos dos conjuntos de datos se combinan y se depuran para eliminar duplicados, creando un único registro de interacción por HCP para el reporte final.

   Resultados (KPIs): Se identificaron y reportaron con éxito el 100% de los HCPs únicos que interactuaron a través de ambos canales. No se produjeron brechas de datos ni problemas de privacidad. El costo por interacción en el canal virtual fue un 60% menor que en el canal presencial, demostrando un modelo de compromiso rentable. Se logró una desviación presupuestaria de <5%.

Guías paso a paso y plantillas

Guía 1: La Lista de Verificación de Auditoría de Cumplimiento Pre-Congreso

Esta guía debe ser completada por el Líder de Cumplimiento 2-4 semanas antes del congreso.

1. Personal:
   • [ ] Confirmar que el 100% de los empleados y contratistas asistentes están en la lista maestra.
   • [ ] Verificar que el 100% del personal ha completado la formación de cumplimiento requerida y ha pasado la evaluación.
   • [ ] Confirmar que las funciones en el lugar (Comercial, Médico, etc.) han sido asignadas y comunicadas.
2. Materiales y Stand:
   • [ ] Realizar un inventario de todos los materiales promocionales y científicos que se envían al congreso.
   • [ ] Verificar que cada pieza del inventario coincide con un código de trabajo aprobado en el sistema PRC.
   • [ ] Revisar las representaciones finales del diseño del stand para asegurar que coinciden con la versión aprobada por el PRC.
   • [ ] Confirmar que no hay artículos promocionales que violen el Código PhRMA (p. ej., bolígrafos, blocs de notas) en el envío. Solo se permiten artículos educativos de valor modesto.
3. Eventos y Actividades de Terceros:
   • [ ] Revisar las agendas de todos los simposios patrocinados para asegurar que son justas y equilibradas.
   • [ ] Confirmar que todos los contratos de los ponentes están completamente ejecutados y que los pagos están alineados con el VJM.
   • [ ] Revisar la logística de cualquier comida o recepción para asegurar que es modesta, en un lugar apropiado y subordinada a un propósito educativo.
   • [ ] Verificar que todos los proveedores (agencias, logística) han recibido y reconocido las políticas de cumplimiento de la empresa.
4. Tecnología y Datos:
   • [ ] Probar la aplicación/dispositivos de captura de ToV para asegurar que funcionan correctamente.
   • [ ] Confirmar que existe un plan para la copia de seguridad y la sincronización diaria de los datos.
   • [ ] Revisar las políticas de privacidad y seguridad de cualquier plataforma digital que se vaya a utilizar.
5. Preparación para Contingencias:
   • [ ] Confirmar que el árbol de escalada de cumplimiento (con números de teléfono móvil) ha sido distribuido a todo el personal.
   • [ ] Revisar los planes de contingencia para escenarios comunes (p. ej., pérdida de materiales, fallo tecnológico).

Guía 2: Qué Hacer y Qué No Hacer en el Stand para el Personal

Una guía de referencia rápida para pegar en el área de personal del stand.

1. HACER:
   • [ ] Usar la credencial del congreso en todo momento.
   • [ ] Escanear la credencial de cada HCP con el que se tenga una discusión sustancial.
   • [ ] Mantener las conversaciones estrictamente dentro de los límites de la etiqueta aprobada por la FDA del producto.
   • [ ] Usar solo materiales promocionales aprobados que estén en exhibición.
   • [ ] Derivar cortésmente todas las preguntas fuera de etiqueta o científicas complejas al personal de Asuntos Médicos uniformado. Frase clave: “Esa es una excelente pregunta. Permítame presentarle a nuestro colega de Asuntos Médicos que es el más adecuado para discutir eso con usted.”
   • [ ] Documentar cualquier solicitud no solicitada de información fuera de etiqueta que se reciba.
2. NO HACER:
   • [ ] Participar en discusiones sobre productos de la competencia, precios o estrategias de reembolso.
   • [ ] Discutir o especular sobre futuros productos, indicaciones o datos no publicados.
   • [ ] Ofrecer o proporcionar comidas o bebidas a los HCP en el stand (a menos que sea parte de un evento aprobado y documentado).
   • [ ] Obstruir el stand de un competidor o hacer comentarios despectivos.
   • [ ] Utilizar materiales de ventas personales o no aprobados (p. ej., notas en un iPad personal).
   • [ ] Prometer o implicar cualquier tipo de quid pro quo a cambio de prescribir o usar el producto.

Guía 3: Flujo de Trabajo de Reporte de la Ley Sunshine Post-Congreso

Un proceso paso a paso para el equipo de finanzas/cumplimiento.

1. Paso 1: Agregación de Datos (Semana 1 Post-Congreso):
   • [ ] Recopilar todos los datos de escaneo de credenciales de los dispositivos de captura de ToV.
   • [ ] Recopilar todos los informes de gastos de los empleados que asistieron.
   • [ ] Recopilar todas las facturas de proveedores relacionadas con los gastos de HCP (p. ej., honorarios de los ponentes, costos de catering).
2. Paso 2: Limpieza y Estandarización de Datos (Semana 2):
   • [ ] Combinar los tres flujos de datos en una única hoja de cálculo maestra.
   • [ ] Estandarizar los nombres de los HCP y los identificadores (p. ej., NPI) para eliminar duplicados.
   • [ ] Hacer coincidir los gastos de los informes y las facturas con las interacciones escaneadas.
3. Paso 3: Reconciliación y Verificación (Semanas 3-4):
   • [ ] Investigar cualquier discrepancia. Por ejemplo, un informe de gastos para una cena con un HCP que no tiene un escaneo de credencial correspondiente.
   • [ ] Realizar una auditoría del 10% de las entradas para verificar su exactitud con la documentación de origen (recibos, contratos).
   • [ ] Asignar cada gasto a la categoría correcta de la Ley Sunshine (p. ej., Comida y Bebida, Compensación por servicios distintos de la consultoría, Viaje y Alojamiento).
4. Paso 4: Revisión y Aprobación (Semana 5):
   • [ ] El analista de reportes presenta el archivo de datos finalizado al Director de Cumplimiento.
   • [ ] El Director de Cumplimiento revisa la integridad y la metodología de los datos.
5. Paso 5: Carga al Sistema (Semana 6):
   • [ ] Formatear el archivo final de acuerdo con las especificaciones de carga del sistema Open Payments de CMS.
   • [ ] Cargar el archivo y resolver cualquier error de validación del sistema.
6. Paso 6: Certificación (Antes de la fecha límite regulatoria):
   • [ ] El CEO o el Director de Cumplimiento certifica formalmente la exactitud y la integridad de los datos presentados en el sistema de CMS.

Recursos internos y externos (sin enlaces)

Recursos internos

• Procedimiento Operativo Estándar (SOP) para la Participación en Congresos Médicos
• Política de la Empresa sobre Interacciones con Profesionales de la Salud de EE. UU.
• Plantilla de Plan de Cumplimiento de Congresos
• Guía de Campo de Cumplimiento en el Lugar (versión de bolsillo)
• Formulario de Solicitud de Información Médica No Solicitada
• Catálogo de Materiales Promocionales y Científicos Aprobados

Recursos externos de referencia

• Código PhRMA sobre Interacciones con Profesionales de la Salud
• Código de Ética de AdvaMed sobre Interacciones con Profesionales de la Salud
• Ley de Pagos a Médicos Sunshine (Sección 6002 de la Ley de Cuidado de Salud Asequible)
• Guía del Programa de Cumplimiento para Fabricantes de Productos Farmacéuticos de la Oficina del Inspector General (OIG) del HHS
• Estándares de la FDA para la Publicidad y Promoción de Medicamentos Recetados
• Estándares para la Integridad y la Independencia en la Educación Continua Acreditada del ACCME

Preguntas frecuentes

¿Cuál es el límite de costo para una comida proporcionada a un profesional de la salud en un congreso?

No hay un límite de dólares federal específico, pero el Código PhRMA exige que las comidas sean “modestas y ocasionales” según los estándares locales. Muchas empresas establecen sus propios límites internos (p. ej., $125-$175 por persona) como una guía de puerto seguro. La comida debe ser secundaria a una presentación educativa o científica sustancial.

¿Podemos pagar el viaje o el alojamiento de un HCP para que asista a un congreso?

Generalmente, no. Pagar el viaje, el alojamiento o la inscripción de un HCP para que asista a un congreso de terceros se considera inapropiado según el Código PhRMA, ya que podría ser visto como un incentivo. La única excepción es si el HCP es un ponente o consultor contratado que presta servicios legítimos a la empresa en el congreso, en cuyo caso el reembolso debe estar cubierto por un contrato y ser de valor justo de mercado.

¿Qué constituye una conversación “fuera de etiqueta” y cómo debe manejarla el personal comercial?

Una conversación “fuera de la etiqueta” implica discutir un producto para un uso (indicación, población de pacientes, dosis) que no ha sido aprobado por la FDA. El personal comercial (ventas, marketing) tiene estrictamente prohibido iniciar o participar en estas discusiones. Si reciben una pregunta no solicitada sobre un uso fuera de la etiqueta, deben declarar que no pueden abordar la pregunta y deben transferir al HCP a un profesional de Asuntos Médicos (MSL), quien puede proporcionar una respuesta científica precisa y no promocional.

¿Qué datos necesito capturar para cada Transferencia de Valor según la Ley Sunshine?

Para cada ToV, debe capturar: el nombre completo del HCP, su dirección comercial, su Número de Identificación de Médico Nacional (NPI), el valor en dólares del artículo/servicio proporcionado, la fecha en que se proporcionó y la naturaleza del pago (p. ej., comida, viaje, honorarios de consultoría). Esta información debe ser reportada anualmente a los Centros de Servicios de Medicare y Medicaid (CMS).

¿Podemos realizar un sorteo o concurso en nuestro stand para atraer tráfico?

No. Los sorteos, concursos o cualquier actividad que ofrezca la oportunidad de ganar un artículo de valor se consideran inapropiados. Se considera un incentivo que no está relacionado con la educación de los HCP. El enfoque para atraer tráfico al stand debe ser la calidad del contenido científico y la experiencia del personal.

Conclusión y llamada a la acción

Navegar por el entorno de los congresos médicos en los EE. UU. exige algo más que una estrategia de marketing brillante; requiere una dedicación inquebrantable a la cumplimiento normativo. Como hemos detallado, un enfoque proactivo y estructurado es fundamental. La implementación de una U.S. medical congress compliance checklist integral es la forma más eficaz de mitigar el riesgo, garantizar la transparencia y fomentar interacciones éticas y significativas con los profesionales de la salud. Al integrar la cumplimiento en cada fase del ciclo de vida del congreso, desde la planificación inicial hasta el reporte final, las empresas pueden proteger su reputación, evitar sanciones costosas y, lo que es más importante, mantener la confianza de la comunidad médica y de los pacientes a los que sirven. El próximo paso para su organización es auditar sus procesos actuales en comparación con este marco, identificar las brechas y capacitar a sus equipos para que defiendan los más altos estándares de integridad.

Glosario

HCP (Healthcare Professional)

Un individuo que proporciona servicios de atención médica, como un médico, una enfermera o un farmacéutico.

PhRMA (Pharmaceutical Research and Manufacturers of America)

Una asociación comercial que representa a las empresas farmacéuticas en los Estados Unidos. Su Código sobre Interacciones con Profesionales de la Salud es un estándar clave de la industria.

OIG (Office of Inspector General)

La Oficina del Inspector General del Departamento de Salud y Servicios Humanos de EE. UU., que combate el fraude, el despilfarro y el abuso en los programas de HHS, incluido Medicare.

FDA (Food and Drug Administration)

La agencia federal responsable de proteger la salud pública asegurando la seguridad y eficacia de los medicamentos, productos biológicos y dispositivos médicos.

Sunshine Act (Physician Payments Sunshine Act)

Una ley federal de EE. UU. que requiere que los fabricantes de productos farmacéuticos y dispositivos médicos informen sobre ciertas transferencias de valor realizadas a médicos y hospitales universitarios.

ToV (Transfer of Value)

Cualquier pago o artículo de valor proporcionado a un HCP, como comidas, viajes, honorarios de ponentes o subvenciones de investigación, que debe ser rastreado y reportado según la Ley Sunshine.

Fair Balance

El requisito de la FDA de que los materiales promocionales deben equilibrar la información sobre la eficacia de un fármaco con la información sobre sus riesgos.

Off-Label Promotion

La promoción de un producto para un uso que no ha sido aprobado por la FDA. Esto está estrictamente prohibido.